It is interesting that of the eight positions identified as being virtually universally conserved in βIII, six of these (35, 124, 189, 239, 275, and 351) are sites where one of the β-tubulins in breast cancer patients mutated to acquire the residue that βIII has in that positions. This evidence concerns the gene CACNA1B and breast carcinoma.